Literature DB >> 22089331

Human miR-31 targets radixin and inhibits migration and invasion of glioma cells.

Dasong Hua1, Dong Ding, Xu Han, Weiyi Zhang, Na Zhao, Gregory Foltz, Qing Lan, Qiang Huang, Biaoyang Lin.   

Abstract

MicroRNAs (miRNAs) are a novel group of short RNAs, about 20‑22 nucleotide in length, that regulate gene expression in a post-transcriptional manner by affecting the stability or translation of mRNAs and play important roles in many biological processes. Many microRNAs have been implicated in glioblastoma. miR-31 is dysregulated in several types of cancer including colon, breast, prostate, gastric and lung cancers. However, the expression and role of miR-31 in glioblastoma are still unclear. In this study, we performed real-time reverse transcriptase polymerase chain reaction (RT-PCR) assays on 10 glioblastoma and 7 normal brain tissues. We found that miR-31 is down-regulated in glioblastoma compared with normal brain tissues. Ectopic expression of miR-31 inhibited migration and invasion ability of U251 glioma cells. Expression profiling analysis revealed that miR-31 affected the cell migration and motility process by regulating migration and invasion related genes. Finally, we demonstrated that miR-31 targeted radixin predominantly via inhibition of protein translation instead of degradation of mRNA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22089331     DOI: 10.3892/or.2011.1555

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  26 in total

Review 1.  NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age.

Authors:  G Kenneth Gray; Braden C McFarland; Susan E Nozell; Etty N Benveniste
Journal:  Expert Rev Neurother       Date:  2014-09-29       Impact factor: 4.618

Review 2.  Function and regulation of microRNA-31 in development and disease.

Authors:  Nadezda A Stepicheva; Jia L Song
Journal:  Mol Reprod Dev       Date:  2016-08-02       Impact factor: 2.609

3.  LncRNA linc01116 prometes glioma cell migration and invasion by modulation of radixin targeted by miR-31.

Authors:  Nan Zhang; Kegang Shuai; Junjun Cheng; Wei Yang; Zhisheng Kan
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

4.  The expression of moesin in astrocytoma: correlation with pathologic grade and poor clinical outcome.

Authors:  Ming Wu; Ding-Yang Liu; Xian-Rui Yuan; Qing Liu; Xin-Jun Jiang; Dun Yuan; Jun Huang; Xue-Jun Li; Zhi-Quan Yang
Journal:  Med Oncol       Date:  2013-01-13       Impact factor: 3.064

5.  A catalogue of glioblastoma and brain MicroRNAs identified by deep sequencing.

Authors:  Dasong Hua; Fan Mo; Dong Ding; Lisa Li; Xu Han; Na Zhao; Gregory Foltz; Biaoyang Lin; Qing Lan; Qiang Huang
Journal:  OMICS       Date:  2012-12

6.  MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.

Authors:  Omer Faruk Bayrak; Sukru Gulluoglu; Esra Aydemir; Ugur Ture; Hasan Acar; Basar Atalay; Zeynel Demir; Serhat Sevli; Chad J Creighton; Michael Ittmann; Fikrettin Sahin; Mustafa Ozen
Journal:  J Neurooncol       Date:  2013-08-03       Impact factor: 4.130

7.  Low p21 level is necessary for the suppressive effects of micoRNA-31 on glioma cell migration and invasion.

Authors:  Jun Pan; Fengfei Lu; Hongchao Xu; Qifu Wang; Chunnan Lin; Shizhong Zhang
Journal:  Tumour Biol       Date:  2016-01-22

8.  miR-31 promotes neural stem cell proliferation and restores motor function after spinal cord injury.

Authors:  Xiao Li; Yuantao Gao; Feng Tian; Ruochen Du; Yitong Yuan; Pengfei Li; Fang Liu; Chunfang Wang
Journal:  Exp Biol Med (Maywood)       Date:  2021-03-09

9.  Novel miRNA-31 and miRNA-200a-Mediated Regulation of Retinoblastoma Proliferation.

Authors:  Vanessa Montoya; Hanli Fan; Paul J Bryar; Joanna L Weinstein; Marilyn B Mets; Gang Feng; Joshua Martin; Alissa Martin; Hongmei Jiang; Nikia A Laurie
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

Review 10.  MicroRNAs: emerging driver of cancer perineural invasion.

Authors:  Mei Zhang; Hong-Chun Xian; Li Dai; Ya-Ling Tang; Xin-Hua Liang
Journal:  Cell Biosci       Date:  2021-06-29       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.